| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property and equipment, net | 27,600,294 | |||
| Prepaid expenses and other current assets | 1,834,245 | |||
| Note receivable | 30,363,798 | |||
| Lease receivable - current | 16,273 | |||
| Inventory | 1,045,612 | |||
| Cash and cash equivalents | 67,679,097 | |||
| Accounts receivable | 649,476 | |||
| Receivable from noncontrolling interests | 0 | |||
| Total current assets | 101,588,501 | |||
| Other noncurrent assets | 1,936,664 | |||
| Operating lease right-of-use assets, net | 1,016,560 | |||
| Lease receivable - noncurrent | 376,314 | |||
| Goodwill | 3,362,650 | |||
| Deferred tax assets | 33,509 | |||
| Total assets | 135,914,492 | |||
| Accrued expenses | 1,792,652 | |||
| Other current liabilities | 489,584 | |||
| Operating lease liabilities - current | 500,873 | |||
| Notes payable - current | 342,080 | |||
| Finance lease liabilities - current | 145,976 | |||
| Deferred revenue | 882,000 | |||
| Accounts payable | 2,600,670 | |||
| Share liability | 149,766 | |||
| Total current liabilities | 6,903,601 | |||
| Operating lease liabilities - noncurrent | 639,419 | |||
| Finance lease liabilities - noncurrent | 518,578 | |||
| Convertible notes payable, at fair value | 98,148,315 | |||
| Notes payable - noncurrent | 1,393,519 | |||
| Total liabilities | 107,603,432 | |||
| Accumulated deficit | -139,681,935 | |||
| Common stock, 0.01 par value 500,000,000 shares authorized, 83,905,417 and 72,068,059 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively | 839,054 | |||
| Additional paid-in capital | 164,045,692 | |||
| Accumulated other comprehensive income (loss) | 29,148 | |||
| Total stockholders' equity attributed to asp isotopes inc. stockholders | 25,231,959 | |||
| Noncontrolling interests in consolidated subsidiaries | 3,079,101 | |||
| Total stockholders' equity | 28,311,060 | |||
| Total liabilities and stockholders' equity | 135,914,492 | |||
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. (ASPI)